{"id":907917,"date":"2025-11-10T19:36:23","date_gmt":"2025-11-11T00:36:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/"},"modified":"2025-11-10T19:36:23","modified_gmt":"2025-11-11T00:36:23","slug":"volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/","title":{"rendered":"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <i>Conference call to take place on <span class=\"xn-chron\">Friday, November 14<\/span> at <span class=\"xn-chron\">8:30 a.m.<\/span> U.S. Eastern Time<\/i>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">HENDERSON, Nev.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Nov. 10, 2025<\/span><\/span> \/PRNewswire\/ &#8212; VolitionRx Limited (NYSE AMERICAN: VNRX) (&#8220;Volition&#8221;) today announces that it will host a conference call on <span class=\"xn-chron\">Friday, November 14<\/span> at <span class=\"xn-chron\">8.30 a.m.<\/span> U.S. Eastern Time to discuss its financial and operating results for the third quarter of 2025 and to provide a business update. Details of this event can be found below.<\/p>\n<p>\n        <b>Event:\u00a0\u00a0 VolitionRx Limited Third Quarter 2025 Earnings and Business Update Conference Call\u00a0<br \/><\/b><br \/>\n        <b>Date:\u00a0\u00a0\u00a0\u00a0 <\/b><br \/>\n        <span class=\"xn-chron\">Friday, November 14, 2025<\/span><br \/>\n        <br \/>\n        <b>Time:\u00a0\u00a0\u00a0 <\/b><br \/>\n        <span class=\"xn-chron\">8:30 a.m.<\/span> U.S. Eastern Time\/<span class=\"xn-chron\">2.30 p.m.<\/span> Central European Time<\/p>\n<p>\n        <b>U.S. &amp; Canada Dial-in: <\/b>1-877-407-9716 (toll free)<br \/><b>U.K. Dial-in: <\/b>0 800 756 3429 (toll free)<br \/><b>Toll\/International: <\/b>1-201-493-6779<br \/><b>Conference ID: <\/b>\u00a013757129<\/p>\n<p>\n        <span class=\"xn-person\">Louise Batchelor<\/span>, Group Chief Marketing &amp; Communications Officer will host the call along with <span class=\"xn-person\">Cameron Reynolds<\/span>, President and Group Chief Executive Officer of Volition, Terig Hughes, Group Chief Financial Officer and Dr. <span class=\"xn-person\">Jake Micallef<\/span>, Chief Scientific Officer. The call will provide an update on important events that have taken place in the third quarter of 2025 and upcoming milestones.<\/p>\n<p>A live audio webcast of the conference call will also be available on this <a href=\"https:\/\/urldefense.proofpoint.com\/v2\/url?u=https-3A__viavid.webcasts.com_starthere.jsp-3Fei-3D1742501-26tp-5Fkey-3D3d18cb9ad9&amp;d=DwMFAw&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=ciEWoItZj33q_tgOwcoRGVPOilVjX7EtJL82EjYwChA&amp;m=0UPHVtN4uAJUvOzqHdBVQPynxdNY_vfiBrvi9MNxnUWpIx-AZvqjCkbIIX3G3ZVT&amp;s=CTvzmViCR6bLMebz8hd4oSBOGpmU1kEObz98q80d7y0&amp;e=\" target=\"_blank\" rel=\"nofollow\">link<\/a>. In addition, a telephone replay of the call will be available until <span class=\"xn-chron\">November 28, 2025<\/span>. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the U.S. and <span class=\"xn-location\">Canada<\/span> and 1-412-317-6671 (toll) internationally. Please use replay pin number 13757129.<\/p>\n<p>\n        <b>About Volition <\/b>\n      <\/p>\n<p>\n        <a href=\"https:\/\/volition.com\/\" target=\"_blank\" rel=\"nofollow\">Volition<\/a> is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, disease and treatment monitoring.<\/p>\n<p>Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help detect and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early detection and monitoring have the potential to not only prolong the life of patients, but also to improve their quality of life.<\/p>\n<p>Volition&#8217;s research and development activities are centered in <span class=\"xn-location\">Belgium<\/span>, with an innovation laboratory and office in the U.S. and an office in <span class=\"xn-location\">London<\/span>.<\/p>\n<p>The contents found at Volition&#8217;s website address are not incorporated by reference into this document and should not be considered part of this document.\u00a0 Such website address is included in this document as an inactive textual reference only.<\/p>\n<p>\n        <b>Media Enquiries:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Louise Batchelor<\/span>, Volition, <a href=\"mailto:mediarelations@volition.com\" target=\"_blank\" rel=\"nofollow\">mediarelations@volition.com<\/a> +44 (0)7557 774620<\/p>\n<p>\n        <b>Investor Relations<br \/><\/b><br \/>\n        <span class=\"xn-person\">Jeremy Feffer<\/span>, LifeSci Advisors, <a href=\"mailto:jfeffer@lifesciadvisors.com\" target=\"_blank\" rel=\"nofollow\">jfeffer@lifesciadvisors.com<\/a> +1-212-915-2568<\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LN20023&amp;sd=2025-11-10\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update-302610111.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update-302610111.html<\/a><\/p>\n<p>SOURCE  VolitionRx Limited<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LN20023&amp;Transmission_Id=202511100845PR_NEWS_USPR_____LN20023&amp;DateId=20251110\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Conference call to take place on Friday, November 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev. , Nov. 10, 2025 \/PRNewswire\/ &#8212; VolitionRx Limited (NYSE AMERICAN: VNRX) (&#8220;Volition&#8221;) today announces that it will host a conference call on Friday, November 14 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the third quarter of 2025 and to provide a business update. Details of this event can be found below. Event:\u00a0\u00a0 VolitionRx Limited Third Quarter 2025 Earnings and Business Update Conference Call\u00a0 Date:\u00a0\u00a0\u00a0\u00a0 Friday, November 14, 2025 Time:\u00a0\u00a0\u00a0 8:30 a.m. U.S. Eastern Time\/2.30 p.m. Central European Time U.S. &amp; Canada Dial-in: 1-877-407-9716 (toll free)U.K. Dial-in: 0 800 756 3429 (toll free)Toll\/International: 1-201-493-6779Conference ID: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-907917","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Conference call to take place on Friday, November 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev. , Nov. 10, 2025 \/PRNewswire\/ &#8212; VolitionRx Limited (NYSE AMERICAN: VNRX) (&#8220;Volition&#8221;) today announces that it will host a conference call on Friday, November 14 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the third quarter of 2025 and to provide a business update. Details of this event can be found below. Event:\u00a0\u00a0 VolitionRx Limited Third Quarter 2025 Earnings and Business Update Conference Call\u00a0 Date:\u00a0\u00a0\u00a0\u00a0 Friday, November 14, 2025 Time:\u00a0\u00a0\u00a0 8:30 a.m. U.S. Eastern Time\/2.30 p.m. Central European Time U.S. &amp; Canada Dial-in: 1-877-407-9716 (toll free)U.K. Dial-in: 0 800 756 3429 (toll free)Toll\/International: 1-201-493-6779Conference ID: &hellip; Continue reading &quot;VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-11T00:36:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LN20023&amp;sd=2025-11-10\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update\",\"datePublished\":\"2025-11-11T00:36:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/\"},\"wordCount\":435,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LN20023&amp;sd=2025-11-10\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/\",\"name\":\"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LN20023&amp;sd=2025-11-10\",\"datePublished\":\"2025-11-11T00:36:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LN20023&amp;sd=2025-11-10\",\"contentUrl\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LN20023&amp;sd=2025-11-10\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/","og_locale":"en_US","og_type":"article","og_title":"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update - Market Newsdesk","og_description":"PR Newswire Conference call to take place on Friday, November 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev. , Nov. 10, 2025 \/PRNewswire\/ &#8212; VolitionRx Limited (NYSE AMERICAN: VNRX) (&#8220;Volition&#8221;) today announces that it will host a conference call on Friday, November 14 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the third quarter of 2025 and to provide a business update. Details of this event can be found below. Event:\u00a0\u00a0 VolitionRx Limited Third Quarter 2025 Earnings and Business Update Conference Call\u00a0 Date:\u00a0\u00a0\u00a0\u00a0 Friday, November 14, 2025 Time:\u00a0\u00a0\u00a0 8:30 a.m. U.S. Eastern Time\/2.30 p.m. Central European Time U.S. &amp; Canada Dial-in: 1-877-407-9716 (toll free)U.K. Dial-in: 0 800 756 3429 (toll free)Toll\/International: 1-201-493-6779Conference ID: &hellip; Continue reading \"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-11T00:36:23+00:00","og_image":[{"url":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LN20023&amp;sd=2025-11-10","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update","datePublished":"2025-11-11T00:36:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/"},"wordCount":435,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LN20023&amp;sd=2025-11-10","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/","name":"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LN20023&amp;sd=2025-11-10","datePublished":"2025-11-11T00:36:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/#primaryimage","url":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LN20023&amp;sd=2025-11-10","contentUrl":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LN20023&amp;sd=2025-11-10"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/907917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=907917"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/907917\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=907917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=907917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=907917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}